Stanford University
Showing 35,901-35,950 of 36,318 Results
-
Yu Zhang
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Yu Zhang's research operates at the intersection of AI, translational neuroscience, and precision medicine. His work focuses on unraveling the complex neurobiological mechanisms underlying cognitive deficits, behavioral dysfunctions, and therapeutic responses in mental health disorders. By integrating advanced machine learning techniques with multimodal brain imaging modalities (e.g., fMRI, DTI, EEG), Dr. Zhang aims to identify neural signatures that reveal the heterogeneity of mental disorders across individuals. A central goal of his research is the development and validation of robust neurobiomarkers to improve diagnostic accuracy, refine prognostic assessments, and guide personalized treatment strategies. His work systematically characterizes brain function and dysfunction to optimize therapeutic interventions, including pharmacological treatments, psychotherapy, and neurostimulation. He is particularly focused on conditions such as Alzheimer’s disease and related dimentia, mood disorders, and neurodevelopmental disorders (e.g., ADHD, ASD), where individualized approaches are essential for improving patient outcomes.
Dr. Zhang has received multiple grants including the NIH R01, R21, Eagles Autism Foundation Translational Grant, Alzheimer's Association Research Grant (AARG), and the Knight Initiative for Brain Resilience and the Rosenkranz Foundation Grants. Beyond foundational research, Dr. Zhang is committed to bridging the gap between computational innovation and clinical application. By collaborating with clinicians, neuroscientists, and engineers, he strives to translate data-driven insights into actionable tools for real-world healthcare settings. His long-term vision is to enable mental health diagnostics and treatment to be guided by objective, biologically grounded biomarkers, thereby enhancing quality of life and long-term outcomes for individuals with psychiatric and neurological conditions.
The Stanford Precision NeuroIntelligence (SPNI) Lab, led by Dr. Zhang, is dedicated to advancing research in AI-driven neuroimaging and precision psychiatry. The lab develops and applies cutting-edge machine learning and deep learning methods to uncover neurobiological mechanisms associated with cognitive and behavioral dysfunctions, as well as treatment responses in mental health conditions. Its mission is to identify translational biomarkers that support precision diagnosis, prognosis, and targeted interventions for mood disorders, neurodevelopmental disorders, and neurodegenerative diseases. -
Yuan Zhang
Basic Life Research Scientist, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordBasic Life Research Scientist
-
Zeyuan Zhang
Postdoctoral Scholar, Hematology-Oncology
BioZeyuan Zhang, Ph.D., is a Postdoctoral Scholar at Stanford University in the laboratory of Glaivy Batusli, where he is conducting research on the evolution of antibody development against the coagulation protein factor IX in hemophilia B disease models. He earned his Ph.D. in Biomedical Science from the University of Iowa, focusing on cell and developmental biology.
Dr. Zhang’s research centers on the molecular mechanisms underlying metabolic disease, with particular emphasis on organelle dysfunction in obesity. His work has provided insights into GSNOR enzymatic activity, lysosomal dysfunction, and inflammatory stress in metabolic regulation. He has also investigated transcriptional mechanisms contributing to obesity-associated hepatic dysfunction and adipose tissue homeostasis. Prior to joining Stanford, he worked as a Scientist I at Altos Labs, where he studied hepatocyte-specific rejuvenation reprogramming in fatty liver disease.
His technical expertise includes multi-omics approaches, RNA sequencing, chromatin immunoprecipitation, high-resolution respirometry, advanced imaging techniques, and in vivo mouse models. He also has extensive experience in primary cell isolation and histological analysis.
Dr. Zhang is interested in translational research that connects molecular mechanisms to therapeutic strategies, with the goal of developing innovative treatments for metabolic diseases. -
Zhe Zhang
Postdoctoral Scholar, Electrical Engineering
BioEPFL Ph.D. in Photonics 2024
-
Zhenglin Zhang
Postdoctoral Scholar, Earth System Science
Current Research and Scholarly InterestsClimate change mitigation and sustainable nutrient management in agroecosystems
-
Zisheng Zhang
Postdoctoral Scholar, Photon Science, SLAC
BioZisheng Zhang is a Stanford Energy Fellow at SUNCAT Center for Interface Science and Catalysis, co-hosted by Dr. Frank Abild-Pedersen (SLAC) and Prof. Thomas Jaramillo (Chemical Engineering). He is interested in physics-steered, complexity-driven, and AI-accelerated simulations for understanding, design, and discovery of novel functional catalysts, materials, molecules, and interfaces.
ZZ grew up in Wuhan and received undergraduate training in both experimental and computational chemistry at South University of Science and Technology of China (with Prof. Jun Li) and University of California, Los Angeles (with Prof. Anastassia N. Alexandrova). He then stayed at UCLA and obtained his M.Sc. and Ph.D. in Theoretical and Computational Chemistry. During PhD study, he did research internship at Argonne National Lab in 2022 with Dr. Maria Chan. -
Chunmei Zhao
Chief Education Solutions Officer, Stanford Engineering Center for Global and Online Education
Current Role at StanfordChief Education Solutions Officer, Stanford Center for Global & Online Education, School of Engineering.
-
Haoqi (Nina) Zhao
Acting Assistant Professor, Civil and Environmental Engineering
BioNina will join Stanford CEE as an Assistant Professor in Summer 2026. Her research bridges computational metabolomics and exposomics to uncover unknown lifestyle chemicals and their impacts on health. Nina earned her B.S. from Peking University, her Ph.D. from the University of Washington, and is currently a postdoctoral scientist at UC San Diego. She received the Pathway to Independence Award (K99/R00) from the National Institutes of Health in 2025.
The Zhao Lab at Stanford will operate at the interface of environmental chemistry, environmental health, and computational mass spectrometry. We aim to identify previously unrecognized chemical drivers that influence human and ecosystem health. We pursue this goal by developing innovative computational and analytical methods centered around untargeted mass spectrometry. Through these efforts, we aim to enable precision environmental health strategies, inform public health policies, and inspire sustainable chemical design.
Current research interests include (but are not limited to):
1.Leveraging mass spectrometry data repositories and advanced informatics tools to systematically map the chemical exposome.
2.Developing tools and resources for mass spectrometry data analysis to advance exposomics research.
3.Investigating host-microbiome-xenobiotic interactions and their impacts on human health.
4.Integrating toxicology with untargeted screening to accelerate the discovery and risk assessment of unknown molecules.
5.Pediatric environmental health: chemical exposures through breastfeeding and their implications for infant development.
6.Traffic-related chemical pollution: environmental fate, occurrence, and relevance to human exposures.
Education
Ph.D., University of Washington, Environmental Engineering (2021)
B.S., Peking University, Environmental Science (2016)
Publications
https://scholar.google.com/citations?user=xW9jBO0AAAAJ&hl=en
Email: hqzhao@stanford.edu -
Heng Zhao
Member, Wu Tsai Neurosciences Institute
Current Research and Scholarly InterestsMy lab is focused on developing novel therapeutic methods against stroke using rodent models. We study protective effect of postconditioning, preconditioning and mild hypothermia. The rationale for studying three means of neuroprotection is that we may discover mechanisms that these treatments have in common. Conversely, if they have differing mechanisms, we will be able to offer more than one treatment for stroke and increase a patients chance for recovery.
